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Purpose: This study was undertaken to determine whether the use of intravascular ultra-
sound (IVUS) during balloon angioplasty and stenting of atherosclerotic aortoiliac
occlusive lesions improved long-term clinical outcome. IVUS has been previously shown
to be more accurate than arteriography in evaluating the deployment of stents in both
peripheral and coronary arteries. Incomplete stent deployment has been anecdotally
identified as a cause of restenosis or occlusion of a treated lesion. To our knowledge,
there have been no previous studies that demonstrate whether the use of IVUS will
affect the long-term patency rate of stented arterial lesions.
Methods: Between March 1992 and October 1995, 52 patients with symptomatic aor-
toiliac occlusive disease underwent balloon angioplasty and stenting of their lesions. We
retrospectively reviewed these cases to determine whether the use of IVUS influenced the
long-term patency rate of these interventions. Follow-up ranged from 1 to 4 years with
a mean of 28 months.
Results: Fifty-two patients had confirmation of adequate stent deployment by arteriog-
raphy. IVUS was used in conjunction with arteriography in 36 patients to evaluate
stent deployment. Patients in the IVUS-assisted group were slightly younger than
those patients who were evaluated solely by arteriography (p < 0.01). No statistical dif-
ferences were noted between the two groups with respect to coronary artery disease,
diabetes mellitus, obstructive pulmonary disease, hypertension, or obesity. Length of
hospital stay, number of stents used, and preoperative ankle brachial indexes were com-
parable in both groups. In the arteriography plus IVUS group, 40% of patients had
underdeployed stents by IVUS evaluation, though they appeared adequately expanded
by arteriography. No restenoses or occlusions were seen in the arteriography plus IVUS
group. Restenosis or occlusion of the stented lesion occurred in 25% of patients evalu-
ated by arteriography alone (p < 0.01). These failures were treated by either thrombol-
ysis or catheter thrombectomy and were then evaluated with IVUS. All were found to
have underdeployed stents. Subsequent treatment consisted of adequate redeployment
of existing stents using IVUS criteria. These salvaged reconstructions have continued
to remain patent.
Conclusions: The use of IVUS may be the best means for assessing adequacy of arterial
stent deployment. Our study suggests that the use of IVUS improves the long-term clin-
ical outcome of balloon angioplasty and stented aortoiliac occlusive lesions. (J Vasc Surg
1998;27:614-23.)
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Arteriography has historically been the standard
used to define arterial anatomy, the extent of occlusive
disease, and the adequacy of endovascular treatment.
Recent clinical experience with intravascular ultra-
sound (IVUS) has shown it to be accurate in evaluat-
ing both arterial disease and the results of endovascu-
lar procedures. IVUS is a catheter-delivered intralu-
minal imaging system that shows the morphologic
features of an occlusive lesion and its relationship to
the structural layers of the vessel wall. IVUS also pro-
vides accurate measurement of the diameter of the
diseased and true lumens of vessels.1,2 Arteriography,
when compared with IVUS, fails to provide accurate
information regarding stent deployment in as many as
40% of patients who undergo iliac artery balloon
angioplasty and stenting.3-8 IVUS identifies underde-
ployed stents, and using true IVUS vessel diameter
measurements these stents can be completely expand-
ed with larger angioplasty catheters.9-11 Incomplete
stent deployment has been anecdotally identified as a
cause of restenosis or occlusion of a treated lesion.
The purpose of this study is to determine
whether the use of IVUS with balloon angioplasty
and stenting of atherosclerotic aortoiliac occlusive
lesions improves long-term clinical outcome.
METHODS
Between March 1992 and October 1995, 52
patients with symptomatic atherosclerotic aortoiliac
occlusive vascular disease received endovascular
treatment consisting of balloon angioplasty and pri-
mary stenting of their occlusive lesions. Indications
for treatment were categorized following the classi-
fication suggested by Rutherford et al.12 and includ-
ed disabling claudication (31 patients; 59.6%),
ischemic rest pain (14 patients; 26.9%) or tissue loss
(seven patients; 13.4%), produced totally or in part
by segmental occlusive lesions in the iliac arteries
documented by both noninvasive lower extremity
arterial vascular testing and arteriography. Epidural
anesthesia was used for 42 patients, four patients
received local anesthesia with intravenous sedation,
and six were treated under general anesthesia
because of technical problems related to epidural
catheter placement or patient preference.
All procedures were performed in a specialized
operating room with a ceiling-mounted surgical C-
arm roentgenographic unit (Fisher Imaging ISS,
Phoenix, Ariz.) and a carbon fiber radiolucent operat-
ing table. An open retrograde femoral approach was
used in 48 patients, and a percutaneous retrograde
femoral route was used in four patients. Thirteen
patients underwent adjunctive open vascular proce-
dures on the femoral or profunda femoris arteries
while undergoing an open femoral approach.
Adjunctive procedures were either endarterectomy
and patch angioplasty of the common/proximal
superficial femoral arteries or standard profundaplasty
(common femoral and profunda femoral endarterec-
tomies with patch angioplasty). These adjunctive out-
flow procedures were equally distributed between the
non-IVUS group (five of 16 patients) and the IVUS-
assisted group (eight of 32 patients). Vascular access
was obtained through 9F sheaths (Cordis, Miami,
Fla.). All patients were therapeutically heparinized. A
0.035-inch Glidewire (Meditech, Watertown, Mass.)
was used to cross the occlusive lesion. Guide catheters
were used when necessary. Treated lesions were man-
aged with IVUS using a 20 or 30 MHz ultrasound
transducer (Hewlett-Packard Sonos Intravascular,
Andover, Md.). All lesions were treated with balloon
angioplasty and primary stenting. Balloon angioplasty
was performed with Blue Max predilators (Meditech,
Watertown, Mass.) for 30 seconds at 10 to 12 atmos-
pheres of pressure. Primary stenting with one or more
Palmaz premounted balloon expandable stents
(Johnson & Johnson International Systems, Warren,
N.J.) were deployed to 8 atmospheres. Pull-down
arterial pressure measurements were made across all
treated lesions. Pharmacologic vasodilatation with
intraarterial pressure determinations to assess for
residual stenosis was not performed in any lesions.
Sixteen patients were evaluated with arteriography
alone. Four of the 16 patients in this group were eval-
uated before the acquisition of IVUS. The other 12
patients were evaluated with arteriography alone
when the IVUS imaging system was being used by the
Division of Cardiology or if the procedure was being
performed at a time when personnel needed to oper-
ate IVUS were not available. In 36 patients (IVUS-
assisted group) IVUS was used to image the arterial
lesions before and after treatment. This was compared
with simultaneous arteriographic information. The
initial balloon size was based on arteriographic data.
In the IVUS-assisted group, stent deployment
was evaluated by IVUS and arteriography. If any
part of the stent was not in complete apposition to
the arterial wall it was considered underdeployed.
Underdeployed stents identified by IVUS under-
went further expansion with a larger angioplasty
catheter until complete stent–to–vessel wall apposi-
tion was achieved. The size of the larger angioplasty
catheter was determined by IVUS measurement of
actual vessel diameter. In all 52 patients a zero pull-
down pressure gradient across each treated lesion
was achieved. After completion of all open proce-
dures, the femoral sheath was removed and the arte-
riotomy was closed with interrupted fine monofila-
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ment horizontal mattress sutures. In the procedures
that were performed percutaneously, the femoral
sheath was removed and pressure applied until
hemostasis was achieved. All patients received peri-
operative antibiotics. After operation all patients
received 162 mg of aspirin and 150 mg of dipyri-
damole daily. No patients received long-term antico-
agulation medication.
Basic data on all patients who underwent success-
ful iliac angioplasty and stent placement during this
time period were prospectively captured in a vascular
registry. For the purpose of this study, the preproce-
dural and postprocedural clinical records, arteri-
ograms, segmental limb pressure measurements, 
and pulse volume recordings were retrospectively
reviewed. Postoperative follow-up of all patients
included clinical evaluation and noninvasive lower
extremity vascular testing at 3, 6, and 12 weeks, and
then at 6-month intervals thereafter. Noninvasive
lower extremity vascular testing consisted of segmen-
tal systolic limb blood pressure measurements, seg-
mental air plethysmographic recordings (pulse vol-
ume recordings), and selective use of Doppler wave-
form evaluation. Duplex imaging was used when
necessary to evaluate stent patency and measure flow
velocities. Repeat arteriography was used in four of
16 patients in the arteriography group when indicat-
ed by abnormal clinical information (severe claudica-
tion or ischemic rest pain) or vascular testing.
Abnormal vascular testing included a 30 mm Hg or
greater segmental pressure drop across the treated
lesion or significant deterioration (category change in
pulse volume recordings) in the affected limb.
The limitations of clinical and noninvasive fol-
low-up in evaluating endovascular procedures on the
iliac arteries required that each intervention be
assessed on a per-limb basis using several hemody-
namic and clinical criteria. Each limb was followed
from the time of the initial procedure to the time of
a second procedure on that artery or to the time of
last follow-up. Determinations of success and failure
are based on the suggested standards for reports that
deal with lower extremity ischemia.12-15
We retrospectively reviewed the records of all
patients in this study. All averages are given as mean ±
SEM. Age, length of stay, numbers of stents deployed,
preoperative ankle-brachial indexes (ABIs), and post-
operative ABIs were analyzed using the two-sample t
test. Other variables, including demographics, com-
plications, restenosis, morbidity, and death were eval-
uated using Fisher’s exact test. p values less than 0.05
indicate statistical significance.
RESULTS
IVUS was used in conjunction with arteriogra-
phy to evaluate the endovascular treatment of 36
patients. Sixteen patients were evaluated by arteriog-
raphy alone. Patient demographics are listed in Table
I. The average age of patients in the IVUS-assisted
group was 61 ± 9 years (range, 38 to 85 years). The
average age of patients evaluated only by arteriogra-
phy was 70 ± 10 years (range, 57 to 87 years), and
Table I. Patient demographics
Without IVUS (%) With IVUS (%) p
Sample size 16 36
Mean age (yr; range) 70 ± 10 (57 to 87) 61 ± 9 (38 to 85) <0.01
Medical history
Coronary artery disease 16 (100) 32 (89) 0.30
Diabetes mellitus 8 (50) 9 (25) 0.11
COPD 11 (69) 30 (83) 0.28
Obesity 2 (13) 4 (11) 1.00
Chronic tobacco use 14 (88) 32 (89) 1.00
COPD, Chronic obstructive pulmonary disease.
Table II. Treatment comparisons
Without IVUS (%) With IVUS (%) p
Sample size 16 36
Mean no. of stents used (range) 2.3 ± 1.0 (1 to 4) 2.5 ± 1.2 (1 to 5) 0.46
Preoperative ABI 0.44 ± 0.12 0.43 ± 0.16 0.91
Length of hospital stay 3.6 ± 2.3 (1 to 10) 2.7 ± 1.1 (1 to 5) 0.61
COPD, Chronic obstructive pulmonary disease.
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this was statistically significant (p < 0.01). No statis-
tical differences were noted between the two groups
with respect to coronary artery disease, diabetes
mellitus, chronic obstructive pulmonary disease,
hypertension, obesity, or length of follow-up. The
length of hospital stay, the number of stents used,
and the preoperative ABI were comparable in both
groups (Table II).
In the arteriography plus IVUS group 36 patients
had 40 treated iliac lesions. The arteriographic site of
treated atherosclerotic disease was the common iliac
artery in 26 patients (72.2%), the external iliac artery
in six patients (16.6%), or a combination of the com-
mon and external iliac arteries in four patients (11.1%).
There were 30 hemodynamically significant iliac artery
stenoses (resting systolic pressure gradient >20 mm
Hg; 83.3%) and six iliac artery occlusions (16.6%) in
the arteriography plus IVUS group. The ipsilateral
superficial femoral artery was documented by arterio-
graphic examination to be widely patent or bypassed
(26 patients; 72.2%), stenotic (four patients; 12.2%),
or occluded (six patients; 16.6%) before iliac artery
stent deployment.
In the 16 patients treated with arteriography
alone, the arteriographic site of treated atheroscle-
rotic disease was the common iliac artery in 13
patients (81.2%) and the external iliac artery in three
patients (18.8%). There were 15 hemodynamically
significant iliac artery stenoses (93.8%) and one iliac
artery occlusion (6.2%). The ipsilateral superficial
femoral artery was documented by arteriographic
examination to be patent in 13 patients (81.2%),
stenotic in two patients (12.5%), or occluded in one
patient (6.2%) before iliac artery stent deployment.
Forty percent (16 of the 40 stented lesions) had
underdeployed stents by IVUS evaluation, although
they appeared adequately expanded by arteriography
(Fig. 1). Further stent expansion with a larger bal-
loon was necessary to achieve accurate stent to ves-
sel wall apposition (Fig. 2). Real-time IVUS imaging
compared with arteriography demonstrated that ves-
sel diameter was underassessed using arteriographic
measurements in 25 of 40 lesions (62%). This differ-
ence in vessel diameter measurements ranged from
1.0 to 4.0 mm (mean, 2.8 mm). It was necessary to
use a larger balloon catheter to accomplish a satis-
factory angioplasty result in the majority of these 25
lesions. Vessel diameter measurements obtained
from arteriography were either a measurement of
lumen diameter above or below the occlusive lesion.
The initial and long-term results of balloon
angioplasty and primary stenting of the iliac artery
Fig. 1. Preintervention arteriogram (A) demonstrates right common iliac artery stenosis
with 8 mm luminal diameter proximal to stenotic lesion. Lesion underwent balloon angio-
plasty with intraluminal stenting using 8 mm balloon, and lesion was imaged after procedure
with arteriography and IVUS. Continued
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occlusive lesions in this study were assessed by clini-
cal, hemodynamic, and angiographic criteria on a
per-limb basis. Clinical follow-up is available for 52
of 52 patients (100%) at a mean of 28 months
(range, 12 to 48 months). The mean length of fol-
low-up was 26.3 months for the IVUS-assisted
group and 28.7 months for patients evaluated by
arteriography alone.
There were no restenoses or occlusions in the
IVUS-assisted group as measured indirectly by the
criteria outlined by Ahn et al.15 A sustained
improvement in the ABI was documented in all 36
patients at the time of last follow-up. The mean ABI
was 0.92, with a mean improvement of 0.39 from
the preoperative measurement (p < 0.000001,
paired t test). No patients in the IVUS-assisted
group underwent repeat arteriographic examination,
although most have had at least one duplex evalua-
tion of their stent. In 12 of 16 patients treated with-
out IVUS a sustained improvement in the ABI at the
time of last follow-up was documented. The mean
ABI was 0.81, with a mean improvement of 0.37
from the preoperative measurement (p < 0.000001).
Restenosis or occlusion of the stented lesion
occurred in 25% (four of 16) of patients treated
without the use of IVUS (p < 0.01) at a mean fol-
low-up of 5.5 months (range, 4 to 7 months). These
four failures were evaluated indirectly by the criteria
outlined by Ahn et al.15 and then underwent arteri-
ographic examinations that documented severe
Fig. 1. Cont’d. Preintervention arteriogram (B). Arteriogram demonstrates adequate result,
but IVUS clearly demonstrates that stent is underdeployed. Stent then underwent expansion
with 10 mm balloon, and arteriographic and IVUS results are shown (C) with complete appo-
sition of stent to vessel wall.
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restenosis or occlusion at the site of stented lesions.
These occlusions were treated by either thromboly-
sis or catheter thrombectomy and all failures were
evaluated with IVUS. Underdeployed stents were
found in all four cases. Subsequent treatment con-
sisted of adequate redeployment of existing stents
using IVUS criteria (Fig. 3). These salvaged recon-
structions have remained patent to date.
Complications occurred in four of 52 patients
(7%). One death occurred from a severe myocardial
infarction within 30 days of the procedure in a
patient evaluated without IVUS (2% overall mortali-
ty rate). One vessel perforation in the IVUS-assisted
group occurred during angioplasty of a heavily calci-
fied vessel and required surgical repair. This vessel
perforation occurred during the initial balloon dilata-
tion before the stent deployment. The initial balloon
size was determined by angiographic criteria, and as
a result the complication was not caused by the use
of either the stent or IVUS. One groin hematoma
occurred in both groups, and one lymphocele devel-
oped in the IVUS-assisted group. These were treated
conservatively. No statistical difference was noted in
the complications in the two groups.
Fig. 2. Arteriogram after balloon angioplasty and intraluminal stenting (without IVUS con-
firmation) in left external iliac artery (A) demonstrates a satisfactory angiographic result with-
out evidence of pressure gradient. Nine months later patient returned with ischemic left foot,
and angiography demonstrated an occluded left external iliac artery (B).
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DISCUSSION
The standard surgical treatment of symptomatic
aortoiliac occlusive disease has traditionally been
prosthetic aortofemoral reconstruction in patients
who have acceptable operative risk. Extraanatomic
bypass procedures (such as axillofemoral or femoro-
femoral) have been used in patients when the oper-
ative risk-to-benefit ratio is high. Prosthetic
aortofemoral revascularization is a very durable pro-
cedure and has an anticipated 3% per year failure
rate. It also has a 3% to 5% perioperative mortality
rate and a 10% to 15% major morbidity rate.
Approximately 40% of patients who require this pro-
cedure survive 5 years. Extraanatomic reconstruc-
tions offer lower morbidity and mortality rates but
also have decreased durability.16
Endovascular treatment of atherosclerotic aor-
toiliac occlusive disease has been shown to be an
acceptable alternative in selected patients. Balloon
angioplasty of an iliac lesion has an anticipated 5-
year patency rate of approximately 59% to 87%.17-20
Endoluminal stenting of lesions that have under-
gone balloon angioplasty improves the patency rate
by reducing the incidence of technical failures and
restenosis.21,22 Recent studies have shown 4- to 6-
year patency rates of 63% to 92% in iliac artery
lesions treated with balloon angioplasty and intralu-
minal stents. Incomplete stent deployment has been
identified as a possible cause for restenosis or occlu-
sion of a treated lesion.23-25
When compared with IVUS, arteriography can
underestimate the degree of stenosis in a diseased
artery because the atherosclerotic lesion occurs
eccentrically. Multiplane arteriographic views would
be necessary to fully evaluate the degree of stenosis
at any given lesion site, and this is not routinely part
of standard arteriographic evaluation. Arteriography
has also been shown to be of limited value in deter-
mining the adequacy of stent deployment.26
IVUS provides 360-degree cross-sectional imaging
of a vessel. It also defines the composition of an occlu-
sive lesion as either soft, fibrous, calcified, or mixed.
IVUS accurately measures diseased and true lumen
diameters of vessels, detects significant intramural dis-
section, and locates major branch vessels.4-11,27
This information can directly alter the technical part of
an endovascular procedure. Heavily calcified vessels
require lower-compliance balloon catheters with high-
er inflation pressures. Dilatation of these calcified ves-
sels should be submaximal to avoid vessel disruption.
This is especially applicable to procedures involving the
external iliac artery. Fibrous lesions have a marked ten-
dency to elastic recoil and are best managed with pri-
mary stenting.
Fig. 3. Lesion underwent thrombolysis (A), and IVUS clearly demonstrated that stent was
underdeployed (B). Underdeployment was corrected by dilation with a larger balloon.
IVUS will clearly define an area where a stent is
not in apposition with the vessel wall. Incomplete
expansion of stents not detected by arteriography
has been noted in 20% to 40% of patients also eval-
uated with IVUS.3,4 One recent study using IVUS
imaging in the coronary circulation showed that
80% of stents needed further balloon expansion for
complete vessel wall apposition despite an optimal
arteriographic result.28
Intravascular stents were developed to improve
the results of balloon angioplasty by compressing
the fractured atheroma, intima, and media to the
vessel wall to maintain the integrity to the newly
established arterial lumen. The use of multiple stents
has been related to both success and failure of bal-
loon angioplasty and stent procedures in the iliac
arterial system.28,29 Sullivan et al.29 studied 288
patients who underwent percutaneous balloon
angioplasty and primary stenting of the iliac arteries
without the use of IVUS. They found that the use of
multiple stents correlated positively with an early
treatment success rate, which was documented by
improved ABIs and thigh-brachial indexes and the
clinical status of the involved limb.29 Others have
found the use of multiple stents have a negative cor-
relation with long-term patency because the need
for multiple stents has been related to a more diffuse
and severe atherosclerotic disease process.23-25 In
the 52 patients in our study, the average number of
stents used in both groups was approximately 2.5
stents per patient. The use of more than two stents
per patient did not appear to affect the initial or
long-term outcome either positively or negatively.
Patency of the superficial femoral artery has also
been identified as a factor influencing the long-term
clinical outcome of balloon angioplasty and stenting
of iliac arteries.12-14 Sullivan et al.29 found patency
of the superficial femoral artery to have a positive
correlation with long-term patency of balloon
angioplasty and stenting in the iliac arteries. Our
results failed to show any evidence that superficial
femoral artery patency affected the long-term out-
come. This may be related to our management of
associated common femoral/profunda femoral arte-
rial occlusive lesions concomitant with iliac balloon
angioplasty and stenting procedures. We perform
almost all of our endovascular procedures by open
exploration and direct surgical repair of the arterial
cannulation site, and we therefore are able to treat
associated occlusive disease in the common
femoral/superficial femoral/profunda femoral arter-
ies using direct surgical repair.
Correct implantation of stents in the coronary
circulation appears to be a key factor in avoiding
acute or subacute occlusion of the treated lesion.
Periprocedural systemic anticoagulation therapy
appears to have no significant impact on patency if
stents were not properly deployed. In a prospective
coronary stent trial, three factors were found to
reduce stent thrombosis: full stent expansion, com-
plete apposition to the vessel wall, and full lesion
coverage during coronary stent placement.30-33 We
believe that our results show that this is also true in
the peripheral circulation.
Our results indicate that a stent must be com-
pletely deployed and in full contact with the vessel
wall if it is to function properly. Immediate and long-
term patency appears directly related to proper stent
deployment.11 Currently, iliac artery angioplasty and
primary intravascular stent placement is regarded as
successful when both angiographic success (brisk flow
through the target vessel without evidence of throm-
bus or dissection, residual stenosis <30%) and hemo-
dynamic success (resting transstenotic pressure gradi-
ent <5 mm Hg) have been achieved. Both of these
criteria were met in the four patients in the group
evaluated by arteriography alone. These four patients
had arteriographic confirmation of treatment failure,
and all had underdeployed stents. These underde-
ployed stents were correctly redeployed using IVUS
criteria, and these retreated lesions have all remained
patent. The lack of a significant pressure gradient
across these treated lesions at the time of their initial
treatment appears to have no predictive value in clin-
ical outcome. Therefore, we believe that proper stent
deployment with complete stent–to–vessel wall appo-
sition is the best indicator for optimal success.
The use of IVUS adds cost to the procedures of
balloon angioplasty and primary stenting. The cost
of our system was shared between the Divisions of
Cardiology and Vascular Surgery. The transducers
that are used are disposable, and each transducer
costs approximately $400. In addition, a technician
must be present to operate the IVUS system.
Currently, there is an approved charge and reim-
bursement for the use of and interpretation of
IVUS. At the time of our study, there was no charge
made for interpretation, and as most of our patients
were insured by either Medicare or managed care,
the use of IVUS equipment was covered in the glob-
al procedural reimbursement. Our results suggest
that the potential long-term benefits with respect to
improved patency rates using IVUS offsets the
expense related to its use.
The weakness of this study is that it is retrospec-
tive. The IVUS-assisted group was significantly
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younger. The reason for the difference in age in the
two groups is because there were several patients in
their late thirties or early forties in the IVUS-assist-
ed group. Sullivan et al.29 have demonstrated that
age is associated with initial and late failure of iliac
artery angioplasty and primary stenting. Therefore,
the age difference between the two groups may have
had some impact on the clinical outcome.29 Several
of the stents placed without IVUS were earlier in the
study period and were under observation for a
longer follow-up period, but this difference was not
statistically significant. Because all stent failures
occurred within the first year of placement (most
within 6 months), longer follow-up time beyond 1
year does not appear to have relevance.
The improved patency rate of iliac lesions after
balloon angioplasty and stenting when IVUS was
used in this retrospective study identifies the need for
a randomized prospective study to truly evaluate the
beneficial influence of IVUS. IVUS imaging will doc-
ument complete stent–to–vessel wall apposition and
accurately define the size to which a vessel should be
dilated. On the basis of the findings in this study, we
believe that IVUS has a positive effect on long-term
clinical outcome of stented iliac occlusive lesions.
We are indebted to Mark Riggs, PhD, who performed
the statistical analysis of the data in this study.
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Dr. Robert B. Rutherford (Silverthorne, Colo.).
How did you decide whether to use IVUS? Was it done on
the basis of specific indications for using it or was it arbi-
trary? In other words, could there be some bias between
these two groups in terms of severity of disease? And, in
the same vein, were there differences in the characteristics
of the lesions that did not get good stent deployment? For
example, did you study calcification, eccentricity, and loca-
tion in addition?
Dr. Frank Arko. Dr. Rutherford, we prefer to use
IVUS in all patients who undergo balloon angioplasty and
stent procedures. There are several reasons why IVUS was
not used in the 16 patients presented by us today. The
IVUS unit that we use is shared with the Division of
Cardiology; it was bought with monies from our two
Divisions. This was done to make the acquisition of the
IVUS unit more cost-effective. Occasionally, the unit is
required by both of us at the same time because of
changes in the operating room schedule, which results in
our needing the unit at the same time that Cardiology is
already using it. Also, if a procedure is performed after
normal work hours, a technician is not readily available to
operate the unit for us and therefore those procedures are
frequently done without the benefit of IVUS.
IVUS provides excellent morphologic information
regarding the character of the lesion that we plan to treat
with angioplasty and stenting. Heavily calcified lesions are
notoriously difficult to dilate and cause some problems
with stent deployment. The information provided by
IVUS in evaluating the morphologic features of the lesion
frequently influences our choice of type of dilation balloon
and the number and size of stents that we choose to
deploy.
We previously reported in the American Journal of
Surgery that IVUS is more accurate in assessing the actual
size to which the vessel should be dilated and stented.
Arteriography underestimates true vessel size by approxi-
mately 2.8 mm. The range was approximately 1 to 4 mm.
This also influences our choice of balloon and stent for the
procedure.
Dr. Rutherford. Was that more likely to occur in the
external iliac artery than in the common iliac artery or at
the bifurcation?
Dr. Arko. It can occur in any vessel, and I honestly
cannot tell you whether it is more frequent in the external
iliac or common iliac arteries.
Dr. John Gray (Durham, N.C.). At Duke, our cardiol-
ogists were using IVUS in their early coronary experience
and essentially learned to overdilate all the lesions. Now
that they’re in the business of dilating peripheral lesions,
they’re doing the same thing and they don’t believe that
IVUS is necessary. Do you have any comeback to that?
Dr. Arko. Dr. Gray, we believe that IVUS is an impor-
tant part of those endovascular procedures that require
balloon angioplasty and stent deployment. Dr. Columbo
from Milan found that in the coronary circulation approx-
imately 80% of stents he placed were underdeployed. He
had to redilate these stents with a large balloon on the
basis of information derived from the use of IVUS. He
then began to routinely overdilate all stented lesions.
However, Dr. Columbo restudied these patients and
found that he still required IVUS in approximately 30% of
the patients to correct procedure-related problems. These
problems could be either eccentric deployment of stents
or problems that developed proximal or distal to the actu-
al site of stent deployment that required additional treat-
ment.
Dr. Gray. Do you think that IVUS will ever replace
arteriography or be the main technique used for placing
stents or stent-grafts in the future?
Dr. Arko. We believe that IVUS provides information
that is essential to the successful completion of balloon
angioplasty and stent procedures. It is not a replacement
for arteriography, which defines the anatomy of the arter-
ial system and the character of the vessels used for access
to the lesion to be treated.
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